Sun Pharma Q2 Results: Net profit jumps 70% to Rs 1,813 crore, beats St estimates

NEW DELHI: Drug maker Sun Pharmaceutical Industries reported a 70.4 per cent jump in net profit at Rs 1,812.79 crore for the quarter ended September. It had reported a net profit of Rs 1,064.09 crore in the same quarter a year ago. An ET Now poll had projected the profit figure at Rs 1,194 crore.

Its total revenue from operations rose 5.29 per cent to Rs 8,553.13 crore, from Rs 8,123.35 crore.

The company said there was an exceptional tax gain for the quarter due to creation of a deferred tax asset amounting to Rs 288.28 crore, arising out of a subsequent measurement attributable to restructuring of an acquired entity.


The company said it continues to monitor the impact of Covid-19 on its business, including its impact on customers, supply-chain, employees and logistics.

Reacting to the results, Sun Pharma shares traded 2.78 per cent higher at Rs 482.25, while Sensex was up 1.27 per cent to 40,262.50 points.